Home›Companies›Biotech & Pharma›Avalor Therapeutics

Avalor Therapeutics, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 5, 2023·Suggest an edit

About Avalor Therapeutics

Avalor Therapeutics is a private company based in Kenmore, Washington, incorporated in 2020 in Delaware. It has reported $335,000 raised in one offering on Form D since December 2023.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 1, 2023Dec 5, 2023$335,000of $800K target6$55,833EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Avalor Therapeutics's Form D filed Dec 5, 2023.

WZ
William Martinez Zegarra
President and director
AF
Anthony Ford
Director
KW
Kenneth Wild
Director

Sources

  1. SECAvalor Therapeutics, Inc. filing history